Association between N-acetyltransferase 2 Polymorphism and Bladder Cancer Risk: Results from Studies of the Past Decade and a Meta-Analysis

Clinical Genitourinary Cancer

Volumn 14, Issue 2, 2016, Pages 122-129

  Wu, Haoran ^a   Wang, Xugang ^a   Zhang, Liang ^a   Mo, Naixin ^a   Lv, Zhong ^a  

^a JIANGSU UNIVERSITY   (China)

Author keywords

Acetylation; Correlation; Genotypes; N acetyltransferase 2; Risk evaluation

Indexed keywords

ARYLAMINE ACETYLTRANSFERASE; NAT2 PROTEIN, HUMAN;

BLADDER CANCER; CANCER RISK; DNA POLYMORPHISM; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENOTYPE; HUMAN; META ANALYSIS; PHENOTYPE; POLYMERASE CHAIN REACTION; PROTEIN ACETYLATION; PUBLISHING; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVIEW; RISK ASSESSMENT; SMOKING; SYSTEMATIC REVIEW; ADVERSE EFFECTS; AGED; BLADDER TUMOR; CASE CONTROL STUDY; FEMALE; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; MALE; MIDDLE AGED; ODDS RATIO; PROCEDURES; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ARYLAMINE N-ACETYLTRANSFERASE; CASE-CONTROL STUDIES; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SMOKING; URINARY BLADDER NEOPLASMS;

EID: 84960392186     PISSN: 15587673     EISSN: 19380682     Source Type: Journal    
DOI: 10.1016/j.clgc.2015.10.007     Document Type: Review

References (63)

1. E.F. Cobain, C.J. Mooney, and D.C. Smith Bladder cancer R.F. Todd III K.A. Cooney, T.G. Hayes, M. Pritchett Mims, F.P. Worden, Tumor Board Review: Guideline and Case Reviews in Oncology 2nd ed 2015 demosMEDICAL New York, NY 175 182
2. R.L. Siegel, K.D. Miller, and A. Jemal Cancer statistics, 2015 CA Cancer J Clin 65 2015 5 29
3. N. Malats, and F.X. Real Epidemiology of bladder cancer Hematol Oncol Clin North Am 29 2015 177 189
4. A.M. Kamat, P.K. Hegarty, J.R. Gee, and et al. ICUD-EAU international consultation on bladder cancer 2012: screening, diagnosis, and molecular markers Eur Urol 63 2013 4 15
5. Z. Kirkali, T. Chan, M. Manoharan, and et al. Bladder cancer: epidemiology, staging and grading, and diagnosis Urology 66 2005 4 34
6. M.A. Knowles, and C.D. Hurst Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity Nat Rev Cancer 15 2015 25 41
7. L.T. Guey, M. García-Closas, C. Murta-Nascimento, and et al. Genetic susceptibility to distinct bladder cancer subphenotypes Eur Urol 57 2010 283 292
8. M. Franekova, E. Halasova, E. Bukovska, J. Luptak, and D. Dobrota Gene polymorphisms in bladder cancer Urol Oncol 26 2008 1 8
9. A.S. Andrew, J. Gui, A.C. Sanderson, and et al. Bladder cancer SNP panel predicts susceptibility and survival Hum Genet 125 2009 527 539
10. R. Minchin, P. Reeves, C. Teitel, and et al. N- and O-acetylation of aromatic and heterocyclic amine carcinogens by human monomorphic and polymorphic acetyltransferases expressed in COS-1 cells Biochem Biophys Res Commun 185 1992 839 844
11. K.P. Vatsis, W.W. Weber, D.A. Bell, and et al. Nomenclature for N-acetyltransferases Pharmacogenetics 5 1995 1 17
12. K. Golka, V. Prior, M. Blaszkewicz, and H.M. Bolt The enhanced bladder cancer susceptibility of NAT2 slow acetylators towards aromatic amines: a review considering ethnic differences Toxicol Lett 128 2002 229 241
13. H. Okkels, T. Sigsgaard, H. Wolf, and H. Autrup Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking Cancer Epidemiol Biomarkers Prev 6 1997 225 231
14. R.L. Teixeira, R.G. Morato, P.H. Cabello, and et al. Genetic polymorphisms of NAT2, CYP2E1 and GST enzymes and the occurrence of antituberculosis drug-induced hepatitis in Brazilian TB patients Mem Inst Oswaldo Cruz 106 2011 716 724
15. J. Yu, Y. Deng, and J.-P. Chen N-acetyltransferase 2 status and gastric cancer risk: a meta-analysis Tumour Biol 35 2014 6861 6865
16. Z. Avraham, O. Baron-Epel, and L. Boker [The relationship between passive smoking, breast cancer risk and N-acetyltransferase 2 (NAT2)] Harefuah 153 2013 171 175
17. M.M. de Lima Junior, L.O. Reis, A.C.T. Guilhen, and et al. N-acetyltransferase-2 gene polymorphisms and prostate cancer susceptibility in Latin American patients Med Oncol 29 2012 2889 2894
18. J.D. Troy, J.L. Weissfeld, B. Diergaarde, and et al. Polymorphisms in NAT2 and GSTP1 are associated with survival in oral and oropharyngeal cancer Cancer Epidemiol 37 2013 505 511
19. G. Osian, L. Procopciuc, L. Vlad, and et al. NAT2 polymorphisms and sporadic colorectal cancer survival J Gastrointestin Liver Dis 19 2010 361 368
20. K. Golka, M. Blaszkewicz, S. Selinski, J.G. Hengstler, and H.M. Bolt NAT2 and bladder cancer - letter Cancer Epidemiol Biomarkers Prev 23 2014 561
21. B. Pesch, K. Gawrych, S. Rabstein, and et al. N-acetyltransferase 2 phenotype, occupation, and bladder cancer risk: results from the EPIC cohort Cancer Epidemiol Biomarkers Prev 22 2013 2055 2065
22. R. Critelli, S. Polidoro, F. Ricceri, S. Guarrera, P. Vineis, and C. Sacerdote Genetic polymorphisms in NAT2 gene influence overall survival in bladder cancer patients Cancer Res 72 2012 3582
23. S. Sanderson, G. Salanti, and J. Higgins Joint effects of the N-acetyltransferase 1 and 2 (NAT1 and NAT2) genes and smoking on bladder carcinogenesis: a literature-based systematic HuGE review and evidence synthesis Am J Epidemiol 166 2007 741 751
24. H.K. Salem, and S. Mahfouz Changing patterns (age, incidence, and pathologic types) of schistosoma-associated bladder cancer in Egypt in the past decade Urology 79 2012 379 383
25. E. Garcia-Martin Interethnic and intraethnic variability of NAT2 single nucleotide polymorphisms Curr Drug Metab 9 2008 487 497
26. E. Scosyrev, K. Noyes, C. Feng, and E. Messing Sex and racial differences in bladder cancer presentation and mortality in the US Cancer 115 2009 68 74
27. D.S. Yee, N.M. Ishill, W.T. Lowrance, H.W. Herr, and E.B. Elkin Ethnic differences in bladder cancer survival Urology 78 2011 544 549
28. B.L. Jacobs, J.S. Montgomery, Y. Zhang, T.A. Skolarus, A.Z. Weizer, and B.K. Hollenbeck Disparities in bladder cancer Urol Oncol 30 2012 81 88
29. M. McGrath, D. Michaud, and I. De Vivo Polymorphisms in GSTT1, GSTM1, NAT1 and NAT2 genes and bladder cancer risk in men and women BMC Cancer 6 2006 239
30. C.-M. Lu, M.-C. Chung, C.-H. Huang, and Y.-C. Ko Interaction effect in bladder cancer between N-acetyltransferase 2 genotype and alcohol drinking Urol Int 75 2005 360 364
31. L. Tao, Y.-B. Xiang, R. Wang, and et al. Environmental tobacco smoke in relation to bladder cancer risk - the Shanghai bladder cancer study Cancer Epidemiol Biomarkers Prev 19 2010 3087 3095
32. D.-K. Song, D.-L. Xing, L.-R. Zhang, Z.-X. Li, J. Liu, and B.-P. Qiao Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China Cancer Detect Prev 32 2009 416 423
33. M. Hosen, J. Islam, M. Salam, M. Islam, M. Hawlader, and Y. Kabir N-acetyltransferase 2 gene polymorphism as a biomarker for susceptibility to bladder cancer in Bangladeshi population Asia Pac J Clin Oncol 11 2015 78 84
34. X. Cui, X. Lu, M. Hiura, H. Omori, W. Miyazaki, and T. Katoh Association of genotypes of carcinogen-metabolizing enzymes and smoking status with bladder cancer in a Japanese population Environ Health Prev Med 18 2013 136 142
35. M. García-Closas, N. Malats, D. Silverman, and et al. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses Lancet 366 2005 649 659
36. J. Gu, D. Liang, Y. Wang, C. Lu, and X. Wu Effects of N-acetyl transferase 1 and 2 polymorphisms on bladder cancer risk in Caucasians Mutat Res 581 2005 97 104
37. L. Covolo, D. Placidi, U. Gelatti, and et al. Bladder cancer, GSTs, NAT1, NAT2, SULT1A1, XRCC1, XRCC3, XPD genetic polymorphisms and coffee consumption: a case-control study Eur J Epidemiol 23 2008 355 362
38. J.-M. Yuan, K.K. Chan, G.A. Coetzee, and et al. Genetic determinants in the metabolism of bladder carcinogens in relation to risk of bladder cancer Carcinogenesis 29 2008 1386 1393
39. L. Fontana, L. Delort, L. Joumard, and et al. Genetic polymorphisms in CYP1A1, CYP1B1, COMT, GSTP1 and NAT2 genes and association with bladder cancer risk in a French cohort Anticancer Res 29 2009 1631 1635
40. A. Zupa, A. Sgambato, G. Bianchino, and et al. GSTM1 and NAT2 polymorphisms and colon, lung and bladder cancer risk: a case-control study Anticancer Res 29 2009 1709 1714
41. D. Ovsiannikov, S. Selinski, M.-L. Lehmann, and et al. Polymorphic enzymes, urinary bladder cancer risk, and structural change in the local industry J Toxicol Environ Health A 75 2012 557 565
42. L. Klimčáková, V. Habalová, M. Sivoňová, V. Nagy, J. Šalagovič, and J. Židzik Effect of NAT2 gene polymorphism on bladder cancer risk in Slovak population Mol Biol Rep 38 2011 1287 1293
43. S. Ouerhani, K. Rouissi, R. Marrakchi, and et al. Combined effect of NAT2, MTR and MTHFR genotypes and tobacco on bladder cancer susceptibility in Tunisian population Cancer Detect Prev 32 2009 395 402
44. K. Rouissi, S. Ouerhani, R. Marrakchi, and et al. Combined effect of smoking and inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1 on bladder cancer in a Tunisian population Cancer Genet Cytogenet 190 2009 101 107
45. J. Lin, A. Kamat, J. Gu, and et al. Dietary intake of vegetables and fruits and the modification effects of GSTM1 and NAT2 genotypes on bladder cancer risk Cancer Epidemiol Biomarkers Prev 18 2009 2090 2097
46. H. Zhao, J. Lin, H.B. Grossman, L.M. Hernandez, C.P. Dinney, and X. Wu Dietary isothiocyanates, GSTM1, GSTT1, NAT2 polymorphisms and bladder cancer risk Int J Cancer 120 2007 2208 2213
47. P.M. Marcus, P. Vineis, and N. Rothman NAT2 slow acetylation and bladder cancer risk: a meta-analysis of 22 case-control studies conducted in the general population Pharmacogenetics 10 2000 115 122
48. L. Moore, D. Baris, J. Figueroa, and et al. GSTM1 null and NAT2 slow acetylation genotypes, smoking intensity and bladder cancer risk: results from the New England bladder cancer study and NAT2 meta-analysis Carcinogenesis 32 2011 182 189
49. K.P. Vatsis, K.J. Martell, and W.W. Weber Diverse point mutations in the human gene for polymorphic N-acetyltransferase Proc Natl Acad Sci U S A 88 1991 6333 6337
50. D.W. Hein, M.A. Doll, A.J. Fretland, and et al. Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms Cancer Epidemiol Biomarkers Prev 9 2000 29 42
51. Di Pietro G, Gadelha SR, Sousa SMB, de Melo PRS, Santos FR. N-acetyltransferase 2: Slow, intermediate or fast? A booming question of the molecular epidemiology in cancer research. Open J Genet 2012; http://dx.doi.org/10.4236/ojgen.2012.24028.
52. A.M. Kamel, G.T. Ebid, and H.S. Moussa N-acetyltransferase 2 (NAT2) polymorphism as a risk modifier of susceptibility to pediatric acute lymphoblastic leukemia Tumour Biol 36 2015 6341 6348
53. F.A. Khalaf, A.A. Basuni, M. El Daly, and et al. Genetic polymorphism of N acetyltransferase 2 and its association with tumor markers and cigarette smoking in hepatocellular carcinoma Egypt J Biochem Mol Biol 31 2014 119 142
54. P. Wang, S. Xie, Q. Hao, C. Zhang, and B. Jiang NAT2 polymorphisms and susceptibility to anti-tuberculosis drug-induced liver injury: a meta-analysis Int J Tuberc Lung Dis 16 2012 589 595
55. C. Gong, X. Hu, Y. Gao, Y. Cao, F. Gao, and Z. Mo A meta-analysis of the NAT1 and NAT2 polymorphisms and prostate cancer: a huge review Med Oncol 28 2011 365 376
56. P. Vineis, F. Veglia, S. Garte, and et al. Genetic susceptibility according to three metabolic pathways in cancers of the lung and bladder and in myeloid leukemias in nonsmokers Ann Oncol 18 2007 1230 1242
57. Q.-W. Ma, G.-F. Lin, J.-G. Chen, and et al. Polymorphism of N-acetyltransferase 2 (NAT2) gene polymorphism in Shanghai population: occupational and non-occupational bladder cancer patient groups Biomed Environ Sci 17 2004 291 298
58. Q. Ma, G. Lin, J. Chen, and et al. N-acetyltransferase 2 genotype, exfoliated urothelial cells and benzidine exposure Front Biosci 4 2011 1966 1974
59. J.H. Lubin, M. Kogevinas, D. Silverman, and et al. Evidence for an intensity-dependent interaction of NAT2 acetylation genotype and cigarette smoking in the Spanish bladder cancer study Int J Epidemiol 36 2007 236 241
60. N. Fujimoto, H. Bui, T. Kubo, H. Inatomi, and R. Hamasuna MP36-02 polymorphisms of membrane transporting gene SLCO1B3 and detoxification enzyme NAT2 associate with bladder cancer susceptibility in smokers J Urol 193 2015 e432
61. J. Gu, and X. Wu Genetic susceptibility to bladder cancer risk and outcome Per Med 8 2011 365 374
62. I. Cascorbi, I. Roots, and J. Brockmöller Association of NAT1 and NAT2 polymorphisms to urinary bladder cancer significantly reduced risk in subjects with NAT1∗10 Cancer Res 61 2001 5051 5056
63. S. Selinski, M. Blaszkewicz, K. Ickstadt, J.G. Hengstler, and K. Golka Refinement of the prediction of N-acetyltransferase 2 (NAT2) phenotypes with respect to enzyme activity and urinary bladder cancer risk Arch Toxicol 87 2013 2129 2139